HERON THERAPEUTICS, INC. /DE/ Quarterly Deferred Tax Assets, Gross in USD from Q4 2011 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
Summary
Heron Therapeutics, Inc. /De/ quarterly Deferred Tax Assets, Gross history and growth rate from Q4 2011 to Q4 2023.
  • Heron Therapeutics, Inc. /De/ Deferred Tax Assets, Gross for the quarter ending December 31, 2023 was $431M, a 1.51% increase year-over-year.
Deferred Tax Assets, Gross, Quarterly (USD)
Deferred Tax Assets, Gross, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $431M +$6.41M +1.51% Dec 31, 2023 10-K 2024-03-12
Q4 2022 $425M +$44.9M +11.8% Dec 31, 2022 10-K 2024-03-12
Q4 2021 $380M +$49.9M +15.1% Dec 31, 2021 10-K 2023-03-29
Q4 2020 $330M +$54.2M +19.7% Dec 31, 2020 10-K 2022-02-28
Q4 2019 $276M +$52.9M +23.7% Dec 31, 2019 10-K 2021-02-24
Q4 2018 $223M +$50.7M +29.5% Dec 31, 2018 10-K 2020-03-02
Q4 2017 $172M +$3.24M +1.92% Dec 31, 2017 10-K 2019-02-22
Q4 2016 $169M +$55.2M +48.5% Dec 31, 2016 10-K 2018-02-27
Q4 2015 $114M +$40.4M +55.2% Dec 31, 2015 10-K 2017-02-23
Q4 2014 $73.3M +$32M +77.7% Dec 31, 2014 10-K 2016-02-19
Q4 2013 $41.2M +$22M +115% Dec 31, 2013 10-K 2015-03-13
Q4 2012 $19.2M +$8.9M +86.4% Dec 31, 2012 10-K 2014-03-07
Q4 2011 $10.3M Dec 31, 2011 10-K 2014-03-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.